Document is current

Article History

Received: 8 April 2020

Accepted: 9 March 2021

First Online: 24 March 2021

Declarations

:

: All study procedures were approved by the Bowdoin College Institutional Review Board (IRB), which served as the central IRB for this study, the Partners Human Research Committee, and carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki). All participants provided online consent prior to engaging in any study activities.

: Data reported within are not identifiable. Consent to publish the results of this study was granted within the original study consent form.

: S.W. has received research support in the form of free medication and matching placebo from Forest Laboratories for clinical trials funded by the NIH. S.W. is a presenter for the Massachusetts General Hospital Psychiatry Academy in educational programs supported through independent medical education grants from pharmaceutical companies; she has received royalties from Elsevier Publications, Guilford Publications, New Harbinger Publications, Springer, and Oxford University Press. S.W. has also received speaking honorarium from various academic institutions and foundations, including the International Obsessive Compulsive Disorder Foundation and the Tourette Association of America. In addition, she received payment from the Association for Behavioral and Cognitive Therapies for her role as Associate Editor for the Behavior Therapy journal, as well as from John Wiley & Sons, Inc. for her role as Associate Editor on the journal Depression & Anxiety. S.W. has also received salary support from Novartis and Telefonica Alpha, Inc. All other authors have no competing interests to report.